Former U.S. Representative Patrick J. Kennedy and Amy Kennedy are well-known advocates for mental health. After all, Patrick founded One Mind for Research and The Kennedy Forum on Community Mental Health, where Amy acts as education director and leads the organization’s objective to improve brain fitness and resilience. So it’s no surprise to hear that Patrick and Amy support Interaxon, the brain health technology company and creator of Muse, the brain-sensing headband that makes meditation easy.
“I am pleased to be joining forces with Interaxon and partnering on important advancements in brain health and wellness, a topic that is near and dear to me,” says Patrick about his and Amy’s appointment as board members to the newly-established Interaxon Advisory Board. “Amy and I strongly support the Interaxon mission to enable people to live happier, healthier lives and we are looking forward to the benefits of this relationship and the positive impact for mental health and wellness as well.”
Patrick, a brain-health advocate and key sponsor of the 2008 Mental Health Parity and Addiction Equity Act, is releasing a book co-authored with Stephen Fried in October. A Common Struggle: A Personal Journey Through the Past and Future of Mental Illness and Addiction, outlines Patrick’s own story while raising a rallying call for equality in the mental health community and recommendations for mental health policy in the future.
“We are thrilled to be joined by Patrick J. Kennedy and Amy Kennedy, two experienced professionals and strong voices in mental health and wellness advocacy, who will be valuable as we continue our rapid growth,” says Ariel Garten, co-founder and CEO of Interaxon, about their appointment. “We are building our robust Interaxon Advisory Board of experienced professionals to help guide the growth of our company as we continue to improve people’s lives through wearable brain sensing technology.”
The Interaxon Advisory Board will augment the Interaxon executive team and provide leadership, guidance and expertise on trends and issues within the brain health and technology industries. It will also act as a leading voice for the company’s interaction with the research, clinical, wellness and performance communities and assist in evaluating new product developments.